Cervical pessary for preterm birth prevention after an episode of arrested preterm labor: a retrospective cohort study with targeted maximum likelihood estimation of the average treatment effect

被引:0
作者
Carpini, G. Delli [1 ]
Giannella, L. [1 ]
Carboni, M. [1 ]
Fichera, M. [1 ]
Pizzagalli, D. [1 ]
Segnalini, N. [1 ]
Conti, C. [1 ]
Tafuri, E. [1 ]
Giuliani, L. [1 ]
Ragno, F. [1 ]
Mancusi, C. [1 ]
Giannubilo, S. R. [1 ]
Ciavattini, A. [1 ]
机构
[1] Univ Politecn Marche, Dept Odontostomatol & Specialized Clin Sci, Obstet & Gynecol Sect, Ancona, Italy
关键词
  Preterm birth; Cervical pessary; Arrested preterm la-bor; Cervical length; Preterm birth prevention; AMNIOTIC-FLUID EMBOLISM; VAGINAL PROGESTERONE; DOUBLE-BLIND; DELIVERY; EPIDEMIOLOGY; INFERENCE; WOMEN;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To evaluate whether cervical pessary effectively reduces the preterm birth < 37 weeks rate in patients who have not delivered after an episode of arrested preterm labor.PATIENTS AND METHODS: Retrospective cohort study was conducted on singleton pregnant patients admitted to our institution be-tween January 2016 and June 2021 for threat-ened preterm labor and who had a cervical length < 25 mm. Women in whom a cervical pes-sary was placed were considered as exposed, while women in whom expectant management was preferred were considered as unexposed. The primary outcome was the rate of preterm birth before 37 weeks. A targeted maximum like-lihood estimation was used to estimate the aver-age treatment effect of cervical pessary by ad-justing for a-priori-defined confounders.RESULTS: A cervical pessary was placed in 152 (36.6%) patients (exposed), while the remaining 263 (63.4%) were managed expectantly (unexposed). The adjusted average treatment effect was-14% (-18 to-11%),-17% (-20 to-13%), and-16% (-20 to-12%) for preterm birth < 37 weeks, < 34 weeks, and < 32 weeks, respectively. The average treatment effect for adverse neonatal outcomes was-7% (-8 to-5%). No difference in gestational weeks at delivery between exposed and unexposed emerged when gestational age at first admission was > 30.1 gestational weeks.CONCLUSIONS: The positioning of a cervical pessary placement may be evaluated to reduce the risk of a subsequent preterm birth after an episode of arrested preterm labor in pregnant patients with onset of symptoms before 30 gestational weeks.
引用
收藏
页码:1058 / 1068
页数:11
相关论文
共 29 条
[1]   Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy [J].
Alfirevic, Zarko ;
Stampalija, Tamara ;
Medley, Nancy .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06)
[2]   Caesarean section versus vaginal delivery for preterm birth in singletons [J].
Alfirevic, Zarko ;
Milan, Stephen J. ;
Livio, Stefania .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (09)
[3]  
[Anonymous], 2016, INT J GYNECOL OBSTET, V127, P29
[4]   Progesterone use after successful treatment of threatened pre-term delivery [J].
Areia, A. ;
Fonseca, E. ;
Moura, P. .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 33 (07) :678-681
[5]  
Behrman RE, 2007, PRETERM BIRTH CAUSES, P6
[6]   Doubly robust nonparametric inference on the average treatment effect [J].
Benkeser, D. ;
Carone, M. ;
van der Laan, M. J. ;
Gilbert, P. B. .
BIOMETRIKA, 2017, 104 (04) :863-880
[7]   Effectiveness of emergency cerclage in cervical insufficiency [J].
Ciavattini, Andrea ;
Carpini, Giovanni Delli ;
Boscarato, Virginia ;
Febi, Tamara ;
Di Giuseppe, Jacopo ;
Landi, Beatrice .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (13) :2088-2092
[8]   How safe is preterm operative vaginal delivery and which is the instrument of choice? [J].
Corcoran, Siobhan ;
Daly, Niamh ;
Eogan, Maeve ;
Holohan, Mary ;
Clarke, Tom ;
Geary, Michael .
JOURNAL OF PERINATAL MEDICINE, 2013, 41 (01) :57-60
[9]   Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial [J].
de Tejada, B. Martinez ;
Karolinski, A. ;
Ocampo, M. C. ;
Laterra, C. ;
Hosli, I. ;
Fernandez, D. ;
Surbek, D. ;
Huespe, M. ;
Drack, G. ;
Bunader, A. ;
Rouillier, S. ;
Lopez de Degani, G. ;
Seidenstein, E. ;
Prentl, E. ;
Anton, J. ;
Kraehenmann, F. ;
Nowacki, D. ;
Poncelas, M. ;
Nassif, J. C. ;
Papera, R. ;
Tuma, C. ;
Espoile, R. ;
Tiberio, O. ;
Breccia, G. ;
Messina, A. ;
Peker, B. ;
Schinner, E. ;
Mol, B. W. ;
Kanterewicz, L. ;
Wainer, V. ;
Boulvain, M. ;
Othenin-Girard, V. ;
Bertolino, M. V. ;
Irion, O. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (01) :80-91
[10]  
Facciolà A, 2022, EUR REV MED PHARMACO, V26, P2610, DOI 10.26355/eurrev_202204_28499